Incbio

Incbio

Innovative tissue engineering solutions for advanced medical applications, specializing in acellular dermal matrices and reconstructive surgery.

HQ location
Seoul, South Korea
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
*
N/A

KRW10.0b

Post IPO Equity
Total Funding000k
Notes (0)
More about Incbio
Made with AI
Edit

LNC Bio is a pioneering company in the field of tissue engineering and medical devices, primarily serving the healthcare sector. The company specializes in developing and manufacturing acellular dermal matrices, which are used in various reconstructive surgeries, including breast reconstruction and skull base surgery. Operating in the global healthcare market, LNC Bio targets hospitals, clinics, and specialized surgical centers as its primary clients. The business model revolves around the research, development, and commercialization of high-quality medical products that meet stringent regulatory standards. Revenue is generated through the direct sale of these medical devices to healthcare providers and through partnerships with medical institutions for clinical trials and product development.

Keywords: tissue engineering, medical devices, acellular dermal matrix, reconstructive surgery, healthcare, breast reconstruction, skull base surgery, clinical trials, product development, global market.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
  • Edit